Profil
Richard Fuller is Chief Executive Officer of Oriel Therapeutics, Inc. and a Fellow of the Royal College of Physicians.
Prior to joining Oriel Therapeutics, he was Head of the Respiratory Clinical Group for Glaxo (now GlaxoSmithKline) and an Executive Director of the Wellcome Trust.
Previously, he was a Director and an Independent Consultant of Science Funding.
Dr. Fuller received a BSc degree in Immunology from University College London, an MBBS from the St. Georges Hospital Medical School London and an MD from the University of London.
Aktive Positionen von Richard Fuller
| Unternehmen | Position | Beginn |
|---|---|---|
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 17.04.2009 |
Ehemalige bekannte Positionen von Richard Fuller
| Unternehmen | Position | Ende |
|---|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services | Direktor/Vorstandsmitglied | - |
Oriel Therapeutics, Inc.
Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Gründer | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Fuller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services | Miscellaneous |
Oriel Therapeutics, Inc.
Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics | Health Technology |
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















